Weigand v. University Hospital of New York University Medical Center

172 Misc. 2d 716, 659 N.Y.S.2d 395, 1997 N.Y. Misc. LEXIS 169
CourtNew York Supreme Court
DecidedApril 1, 1997
StatusPublished
Cited by8 cases

This text of 172 Misc. 2d 716 (Weigand v. University Hospital of New York University Medical Center) is published on Counsel Stack Legal Research, covering New York Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Weigand v. University Hospital of New York University Medical Center, 172 Misc. 2d 716, 659 N.Y.S.2d 395, 1997 N.Y. Misc. LEXIS 169 (N.Y. Super. Ct. 1997).

Opinion

OPINION OF THE COURT

Karla Moskowitz, J.

I. BACKGROUND

This action involves a death from Acquired Immune Deficiency Syndrome (AIDS), allegedly caused by a transfusion of blood contaminated with the human immunodeficiency virus (HIV). The transfusion took place during triple coronary artery bypass surgery at University Hospital of New York University [718]*718Medical Center (University Hospital) in February 1983. In addition to suing University Hospital, University Hospital Blood Bank (Blood Bank) and decedent’s physician, plaintiff has also sued the blood-banking industry’s national trade association, the American Association of Blood Banks (AABB), which now moves to dismiss the complaint pursuant to CPLR 3013 and 3211 (a) (7).

The complaint contains four causes of action. In the first count, plaintiff claims essentially that AABB negligently established deficient blood collecting standards that were not in keeping with the state of scientific knowledge, that the alleged transmission of HIV to the decedent resulted from the collection of blood in accordance with such negligently established standards and that plaintiff was damaged as a result. The second cause of action seeks further damages as a result of the same conduct for financial and economic benefits that would have accrued to plaintiff’s estate had decedent lived. In the third and fourth causes of action, plaintiff claims that defendants failed to advise decedent and his family of the option of donating his own blood or obtaining family blood donations and failed to warn decedent of the risk of HIV transmission from blood and plasma transfusions.

AABB’s motion to dismiss is directed at both the adequacy of plaintiff’s pleadings and the legal duties and responsibilities, if any, of AABB to the recipient of a blood transfusion.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Grubin v. Rattet (In Re Food Management Group, LLC)
380 B.R. 677 (S.D. New York, 2008)
Newman v. Motorola, Inc.
125 F. Supp. 2d 717 (D. Maryland, 2000)
N.N v. v. American Ass'n of Blood Banks
89 Cal. Rptr. 2d 885 (California Court of Appeal, 1999)
Bailey v. Edward Hines Lumber Co.
Appellate Court of Illinois, 1999

Cite This Page — Counsel Stack

Bluebook (online)
172 Misc. 2d 716, 659 N.Y.S.2d 395, 1997 N.Y. Misc. LEXIS 169, Counsel Stack Legal Research, https://law.counselstack.com/opinion/weigand-v-university-hospital-of-new-york-university-medical-center-nysupct-1997.